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Evolutiona b s t r a c t
Aminoacyl-tRNA synthetases (aaRSs) are ubiquitous and ancient enzymes, mostly known for their
essential role in generating aminoacylated tRNAs. During the last two decades, many aaRSs have
been found to perform additional and equally crucial tasks outside translation. In metazoans, aaRSs
have been shown to assemble, together with non-enzymatic assembly proteins called aaRSs-
interacting multifunctional proteins (AIMPs), into so-called multi-synthetase complexes (MSCs).
Metazoan MSCs are dynamic particles able to speciﬁcally release some of their constituents in
response to a given stimulus. Upon their release from MSCs, aaRSs can reach other subcellular
compartments, where they often participate to cellular processes that do not exploit their primary
function of synthesizing aminoacyl-tRNAs. The dynamics of MSCs and the expansion of the aaRSs
functional repertoire are features that are so far thought to be restricted to higher and multicellular
eukaryotes. However, much can be learnt about how MSCs are assembled and function from
apparently ‘simple’ organisms. Here we provide an overview on the diversity of these MSCs, their
composition, mode of assembly and the functions that their constituents, namely aaRSs and AIMPs,
exert in unicellular organisms.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
During ribosomal protein synthesis, mRNA codons are
decoded through base pairing with the anticodon of aminoacy-
lated tRNAs. Therefore, maintenance of the genetic code and of
the information stored as nucleotide triplets in genes relies on
the rules that govern the recognition of a given tRNA by its cor-
responding aminoacyl-tRNA synthetase (aaRS) [1]. The term
‘second genetic code’ has been introduced to describe this con-
cept [2]. AaRSs belong to one of the most ancient family of pro-
teins and are mainly known for their primary function, which is
to charge each tRNA species with its cognate amino acid (aa)
[3]. Originally characterized and isolated in the late 50s and
early 60s [4–6], aaRSs have been extensively studied since then.
Interestingly, the propensity of several aaRSs to form complexes
called multi-synthetase complexes (MSCs) was already discov-
ered in the early 1970’s [7,8]. Their potential to assemble intosupramolecular complexes was initially discovered in mammals,
in which the MSC is composed of eight aaRSs and three auxil-
iary proteins, named ‘aminoacyl-tRNA synthetase-interacting
multifunctional proteins’ (AIMP) [7,8]. MSC formation was
believed to be restricted to higher eukaryotes, as the 20 aaRSs
isolated either from Saccharomyces cerevisiae or from Escherichia
coli were found to be only in a free form [9,10]. However,
although all aaRSs from E. coli were initially puriﬁed in their
free forms using a methodology combining ion-exchange and
adsorption chromatography, the existence of an MSC in E. coli
was reported a decade later [11]. So far, this is the only study
reporting the presence of MSCs in the bacterial branch of the
tree of life. This study was not pursued any further, as, during
the next decades, research mostly focused on deciphering the
molecular determinants that determine the tRNA–aaRS recogni-
tion [12].
From an evolutionary point of view, the accepted scheme is that
primitive aaRSs contained solely a contemporary catalytic core
that was capable of activating aa. New domains were later
recruited to these amino acid-activating polypeptides, either by
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that corresponded to the contemporary tRNA acceptor arm
(accepting minihelix) [13]. These primitive tRNA–aaRS pairs then
evolved, mainly through accretion of new domains (e.g. of the anti-
codon minihelix and anticodon-binding domain) to give rise to the
modern tRNAs and aaRSs. Although the details of their evolution-
ary history are still a matter of debate, the modular organization
of aaRSs strongly suggests that they result from a piece-wide
sequential addition of domains to the aa-activating core [3,14].
Besides the anticodon-binding domain, other functional domains,
including the editing domains [15] were later added to the aaRS
sequence, as well as modules that have not been assigned any
function so far [16–18]. Contemporary aaRSs should thus be
regarded as catalytic folds that attracted, throughout evolution,
several other independent modules, which are not necessarily
associated with tRNA aminoacylation.
Some of these additional modules are made of folds that are
typically involved in protein–protein interactions, as, for example,
the glutathione transferase (GST) domain. Such modules might
have allowed aaRSs to assemble into complexes, like the MSCs
[19,20]. Others domains, like the EMAP II domains, might have
allowed aaRSs to accomplish tasks that are completely unrelated
to protein synthesis [21]. It has even been proposed that the capac-
ity of these multitasking enzymes to assemble in MSCs allows for
both enhanced efﬁciency of tRNA aminoacylation of the participat-
ing aaRSs [22–24] and annexation of this essential and central pro-
cess of aminoacyl-tRNA (aa-tRNA) synthesis to other cellular
pathways [25–27].
The evolutionary origin of MSCs is still unclear, and the
advantage brought in by the accretion of aaRSs into MSCs was
for a long time an open question. Recently, it was proposed that
metabolic events might have facilitated the incorporation of as
many as eight aaRSs into the MSCs of higher eukaryotes [25].
The consensual concept that has emerged during the last decade
is that MSCs are reservoirs for releasable and multifunctional
aaRSs [28–30]. Sequestration inside MSCs conﬁnes aaRSs activi-
ties to their primary tRNA charging activity, while they can carry
out alternative regulatory roles upon release. As most of these
non-conventional roles include regulation of gene expression
[27,31] or participation in a signaling pathway [32], the released
aaRSs often relocate to a new subcellular compartment (e.g. the
nucleus or the mitochondrion) [26,27,31]. However, it is not
known if the nuclear relocalization of MSC-released aaRSs is
independent or not of regular nuclear import mechanisms that
have been associated with aaRS-mediated tRNA channeling or
the control of tRNA integrity and functionality [33,34]. All
eukaryotic MSCs characterized so far were primarily isolated
from cytosolic fractions [24,35], thus, these complexes are con-
sidered to be exclusively restricted to the cytosol. Consequently,
they can act as a dynamic cytosolic anchors for relocating aaRSs
[27]. However, the presence of MSCs in other subcellular com-
partments was so far not exhaustively investigated. There is
even one study reporting the presence of a complex containing
13 aaRSs in nuclear extracts from Chinese hamster ovarian cells
and rabbit kidney cells [36]. This complex was proportionally
less abundant than its cytosolic orthologue, but was shown to
be more stable, suggesting that it might not be as dynamic as
the cytosolic MSC and, thus, more likely to be involved in tRNA
export from the nucleus.
In this review, we focus on the various features of the MSCs that
have been identiﬁed in low-complexity organisms such as bacteria,
archaea, fungi and protozoans. We describe their components
(aaRSs and AIMPs), their domain architectures and assembly
modes and by comparing them to those found in MSCs from
multicellular organisms, we propose that MSCs segregate in two
different evolutionary types.2. Main text
2.1. MSCs composition and functions in low-complexity organisms and
in metazoan
Overall, most of the knowledge on MSCs almost exclusively
originates from studies made on a few metazoan species and espe-
cially on human cells. As a consequence of this narrow sampling of
the species in which MSCs have been looked for and characterized,
we have a biased view of the function of these complexes. Based on
their expected roles of dynamical platforms for relocating aaRSs,
the presence of MSCs in prokaryotes, in which the quasi-totality
of the cellular processes takes place in a single compartment,
would be difﬁcult to explain. In addition, there are contradicting
reports concerning the presence of MSC in some prokaryotes and
their compositions have not always been fully deciphered. Finally,
when tested, the only role that could be attributed to MSCs from
low-complexity organisms was an enhancement of the tRNA
aminoacylation efﬁciency of their participating aaRSs [24], making
these complexes apparently less interesting to study than their
metazoan orthologues.
2.1.1. Bacterial MSC
In 1987, almost a decade after the puriﬁcation of 20 individual
aaRSs from E. coli, a study reported the isolation of a MSC from the
same bacterial species [11]. Strangely, depending on the method
used to break cells, the molecular weight of the complex varied
from 1 MDa (freeze press) to 400 kDa (sonication). The complex
could only be isolated on 6% agarose columns but not by regular
size-exclusion chromatography on Sephadex-based columns. This
complex does not seem to contain all E. coli aaRSs, since, given
the pool of aaRSs present in this species, the expected size of a
MSC containing all of them would be of 2.4 MDa. This discrepancy
in the size of the complex, suggests that the strength of the pro-
tein–protein interactions mediating the assembly of the complex
is extremely weak. Moreover, such a MSC has never been isolated
from any of the numerous other bacterial species from which
aaRSs have been extracted and puriﬁed; and this study still is the
only one reporting the presence of a MSC in E. coli. For these rea-
sons, the existence of bacterial MSCs remains, to our opinion, to
be clearly demonstrated, despite the fact that bacterial aaRSs have
indeed been found to form complexes [37,38]. However, these
complexes cannot be considered as MSCs per se, since they only
contain a single aaRS species.
2.1.2. Archaeal MSCs
2.1.2.1. Haloarcula marismortui. The ﬁrst archaeal MSC that has
been described was isolated from H. marismortui [39]. This halo-
philic and marine organism contains one or two big complexes that
include almost all twenty aaRSs (Fig. 1). This complex is resistant
to dissociation when subjected to various chromatographic separa-
tions (size-exclusion, ion exchange, hydroxyapatite and reversed
phase). However, no additional information concerning the pres-
ence or absence of non-enzymatic anchoring proteins (AIMPs) or
concerning the potential role of this MSC is available.
2.1.2.2. Methanothermobacter thermautotrophicus. The methano-
genic archaea M. thermautotrophicus contains a well-characterized
MSC. This complex represents the best-studied archaeal MSC, so
far [30,40–42]. This macromolecular ediﬁce is composed of 3
aaRSs: leucyl- (LRS); prolyl- (PRS); and lysyl-tRNA synthesae
(KRS), and the elongation factor 1A (EF-1A) (Fig. 1). The presence
of LRS seems to be essential, as it probably acts as an assembly
factor for PRS, KRS and EF-1A. When subjected to size-exclusion
chromatography, the three aaRSs coelute at high molecular weight
(600 kDa) suggesting that they assemble with a 2-2-2
Fig. 1. Composition and architecture of all characterized MSCs. Schematized phylogenetic tree presenting the various organisms in which a MSC has been identiﬁed and the
corresponding illustration of the MSC’s architecture and/or composition. The one-letter code is used for each aaRS (gray). K1 and K2 refer to Class 1 and Class 2 KRSs,
respectively.
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LRS, respectively, whereas EF-1A binds the connective peptide
(CP1) of LRS that is responsible for its amino acid proofreading
activity [43]. This CP1 domain is a post-transfer editing domain,
and its activity is not affected by EF-1A binding. Within the com-
plex, the catalytic efﬁciency of PRS and KRS is improved. When
bound to EF-1A, LRS displays an increased tRNA aminoacylation
efﬁciency owing to an 8-fold increased kcat for Leu-tRNALeu synthe-
sis compared to free LRS. A modest enhancement of EF-1A GTP
hydrolysis is also observed when this factor is bound to LRS. In
the light of these observations, it was proposed that the M. ther-
mautotrophicus MSC intensiﬁes aa-tRNA channeling (at least in
the case of Leu-tRNALeu, Pro-tRNAPro, Lys-tRNALys) from amino-
acid–tRNA synthesis to its delivery to translating ribosomes.
A second MSC has been identiﬁed in M. thermautotrophicus via
protein–protein interaction detection methods, in which arginyl-
tRNA synthetase (RRS) was used as bait. This second complex
contains two aaRSs: seryl-tRNA synthetase (SRS); and RRS. The lat-
ter was found to interact with its tRNAArg substrate within the
complex [23] (Fig. 1). The ribosomal proteins L7 and L12, which
are normally located at the ribosome stalk, have also been found
to participate in this complex [44]. Although the activity of RRS
was shown to remain unaffected within this complex, the activity
of SRS shows a 4-fold increase as compared to the free enzyme.
Similarly, the catalytic activity of SRS increases with temperature
and salt concentration when associated with RRS. It was proposed
that this MSC is involved in tRNAs recycling, as its association withtranslating ribosomes may help to avoid tRNA diffusion, and pro-
mote fast tRNA re-aminoacylation to enable immediate re-used
for the decoding of the next downstream mRNA codons.
2.1.2.3. Methanocaldococcus jannaschii. InM. jannaschii, PRS was co-
puriﬁed with the protein encoded by the Mj1338 ORF. This protein
has been annotated as a putative metabolic enzyme involved in
methanogenic metabolism [45] (Fig. 1). This enzyme has been
identiﬁed as an inactive paralogue of Hmd (H2-forming methylene-
tetrahydromethanopterin dehydrogenase). It has been shown that
in Methanothermobacter marburgensis, HmdII and HmdIII, two
other paralogues of Hmd, do not exhibit Hmd activity [46]. Inter-
estingly, transcription of the genes coding for HmdII and HmdIII
is regulated by H2 concentration: transcription of hmdII is up reg-
ulated and that of hmdIII is down regulated under H2-limited
growth conditions. These ﬁndings suggest that HmdII and HmdIII
are indirectly involved in methanogenesis. In M. jannaschii,
HmdII/Mj1338 and HmdIII can bind to both PRS and tRNAPro,
thereby forming ternary complexes. However the precise architec-
tures of these particles have not yet been established [47]. HmdII/
Mj1338 also binds other archaeal aaRSs such as KRS and aspartyl-
tRNA synthetase (DRS), suggesting the existence of another HmdII/
Mj1338-containing MSC in this archaeal species. The systematic
presence of an enzyme involved in methanogenesis in the M. jann-
aschii MSCs pinpoints toward a possible link between energy
production and translation. Thus, it is possible that in methanogenic
archaea MSCs can couple energy production to energy use for
D. Laporte et al. / FEBS Letters 588 (2014) 4268–4278 4271protein synthesis in response to environmental conditions. How-
ever, an Mj1338-containing MSC remains questionable, since it
was not ruled out whether these aaRSs co-bind together to
Mj1338 or bind separately in the original paper. Mj1338 was
shown to also bind, separately, human KRS and PRS by the same
method, suggesting a potential non-speciﬁc protein interaction.
2.1.2.4. Thermococcus kodakarensis. In T. kodakarensis, afﬁnity puri-
ﬁcation chromatography using LRS as bait resulted in the co-elu-
tion of 5 other aaRSs: PRS; tyrosyl- (YRS); glycyl- (GRS);
methionyl- (MRS); and cysteinyl-tRNA synthetase (CRS), together
with EF-1A, elongation factor 2 (EF-2), initiation factor 2 (IF-2)
and -2B (IF-2B) and several ribosomal proteins [48] (Fig. 1). In
agreement with the composition of this MSC, puriﬁed ribosome
fractions of T. kodakarensis exhibited the tRNA aminoacylation
activities of PRS, LRS and YRS, conﬁrming the association between
these aaRSs and the protein synthesis machinery. Additionally, the
catalytic efﬁciency of LRS was found to be increased when it asso-
ciates with EF-1A in its GTP-bound form but not in the GDP-bound
state. This indicated that only the activated elongation factor could
act as an enhancer for LRS. As a consequence, the T. kodakarensis
MSC was proposed to increase the activities of its associated aaRSs
in order to boost the rate of protein synthesis.
2.1.2.5. Methanosarcina barkeri. In M. barkeri, monomethylamine
methyltransferase genes contain amber stop codons that are
reassigned to pyrrolysine (Pyl) [49]. For their translation, the
monomethylamine methyltransferase mRNAs require synthesis
of a Pyl-charged amber suppressor tRNA pyrrolysine (tRNAPyl).
M. barkeri was shown to use two different strategies to generate
pyrrolysyl-tRNAPyl (Pyl-tRNAPyl). The ﬁrst pathway is essential,
and involves the direct aminoacylation of tRNAPyl with Pyl by a
pyrrolysyl-tRNA synthetase [50]. A second and additional pathway
involves both class 1 KRS (KRS1) and class 2 KRS (KRS2), which
misacylate tRNAPyl with lysine, as well as a still unidentiﬁed
tRNA-dependent amino acid-modifying enzyme that converts this
mischarging lysine into Pyl. Interestingly, lysylation of tRNAPyl by
KRS1 and KRS2 can only be achieved through the formation of a
ternary complex, in which tRNAPyl is sandwiched by both KRSs,
as each KRS is individually unable to mischarge tRNAPyl [51]
(Fig. 1). In this complex, KRS1 acts as a stabilizer, whereas KRS2
catalyses misacylation of tRNAPyl with lysine. However, the rate
of tRNAPyl charging is 100-fold slower, compared to the one of
the cognate tRNALys by each of these KRSs. It was thus surmised
that this complex is more likely to be involved in modulating the
level of suppressing Pyl-tRNAPyl available in the cell.
2.1.3. Fungal MSCs
2.1.3.1. S. cerevisiae. The AME (Arc1p-MRS-ERS) complex from
S. cerevisiae is one of the most studied MSCs. This complex was dis-
covered in the mid 1990’s and is made of two aaRSs—MRS and
glutamyl-tRNA synthetase (ERS)—and one AIMP, Arc1p, which is
homologous to the AIMP1/p43 assembly factor of the mammalian
MSC [24,52] (Fig. 1). Arc1p was initially identiﬁed as a cofactor for
nuclear export of tRNA by Hurt and colleagues, who used the syn-
thetic lethality approach to identify a genetic relationship between
the LOS1 (encoding an exportin) and ARC1 (encoding Arc1p) genes
[24].
Arc1p acts as an ark for the two aaRSs [53,54]. It speciﬁcally
binds the N-terminal GST-like domains of MRS and ERS via the
GST-like domains that are located in its N-terminus. Complete
deletion of N-terminal extensions of the two aaRSs is not lethal,
but abolishes their interaction with Arc1p. Formation of the AME
complex causes nuclear exclusion of the three AME proteins, as
Arc1p is actively excluded from the nucleus through the Xpo1p-
dependent nuclear export pathway [55]. Indeed, even whenartiﬁcially fused to a strong nuclear localization signal, Arc1p is
still very efﬁciently exported from the nucleus, suggesting that
Arc1p contains a strong nuclear export signal (NES), although a
classical leucine rich NES (target of Xpo1) has not been clearly
identiﬁed. The accumulation of Arc1p–NLS fusion protein in the
nucleus of yeast xpo1 mutant strain conﬁrmed the presence of a
strong NES. Notably, deletion of the N-terminal sequence of Arc1p
allows its entry in the nucleus, suggesting that the Arc1p NES is
located within this protein region [56]. Along the same line, dele-
tion of ARC1 results in nuclear relocation of MRS and to a lesser
extend, of ERS [56]. However, the mechanism and structural deter-
minants governing the nuclear relocation of Arc1p, MRS and ERS
remain to be identiﬁed. Moreover, although nuclear localization
of Arc1p can be fully understood given its expected role in export-
ing tRNA from this organelle, the function of ERS and MRS in the
nucleus remains puzzling. One possibility would be that they par-
ticipate in a quality control step for newly transcribed tRNAs, as
also suggested for other nucleus-localizing aaRSs in other organ-
isms [33,34]. It is still unknown whether all or only a subset of
the aaRSs are capable of entering the nucleus, and whether MSCs,
like the AME complex, control nuclear localization of their aaRS
components. As only a few such MSCs have been characterized
so far, one could speculate that, if they exist, they must be highly
dynamic.
For a long time after its discovery, the function of the S. cerevi-
siae AME complex had been associated with the improvement of
the tRNA aminoacylation efﬁciency (kcat/KM) of MRS and ERS
[24,57]. This efﬁciency enhancement is mediated by the tRNA
binding domain in the C-terminus of Arc1p that probably compen-
sates for the low afﬁnity of MRS and ERS for their cognate tRNAs
[58]. Therefore, the catalytic efﬁciency of Arc1p-bound MRS is
increased by 500-fold as compared to the free enzyme. However,
another study reported only a 3 to 4-fold increase of the aminoacy-
lation efﬁciency of MRS upon binding to Arc1p, leaving unclear the
degree by which Arc1p enhance the charging efﬁciency of MRS
[59]. This gain in tRNA aminoacylation efﬁciency is mainly due to
an Arc1p-mediated lowering of the KM of MRS for its cognate tRNA
[24], which allows AME-assembled MRS to be far more efﬁcient at
low tRNAMet concentrations. Similarly to MRS, the catalytic efﬁ-
ciency of Arc1p-bound ERS is enhanced compared to the free
enzyme, owing to a 100-fold increase in the afﬁnity of Arc1p-
bound ERS for its cognate tRNAGlu [57].
Interestingly, both Arc1p-bound MRS and free MRS have been
shown to mismethionylate tRNAs in vivo and in vitro under oxida-
tive stress [60]. These mischarged Met-tRNAs are subsequently
used during translation generating proteins containing misincor-
porated methionines. Previous reports showed that these addi-
tional methionine residues can protect the proteins against
reactive oxygen species (ROS) [61,62]. If these misincorporated
methionines replacing non-methionine residues are, for example,
located near the active site of an enzyme, their oxidation will
shield this strategic position against ROS. The AME complex would
not be necessary for this defense mechanism in vivo, since the
extent of mismethionylation does not vary between a wild type
and an arc1D strain, suggesting that MRS alone might be able to
mismethionylate tRNAs [60]. However, it is still not known
whether binding to Arc1p also enhances the charging efﬁciency
of MRS for non-cognate tRNAs, like it does for its cognate tRNAMet.
If this would be the case, the AME complex would not then
increase the extent of protection against ROS but could modify
the speed of the response to oxidative stress.
The fact that S. cerevisiae MRS and ERS are far more efﬁcient in
tRNA charging when assembled in the AME complex than in their
free forms suggested that the role of this MSC would strictly be
conﬁned to improve aa-tRNA synthesis. For that reason the AME
MSC was not considered to be a dynamic complex and the
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exhaustively checked. Recently it was shown that when yeast cells
switch from fermentation to respiration expression of Arc1p is
decreased [27] triggering the release of ERS. Free ERS is then able
to relocate to the mitochondria and act as a mitochondrial non-dis-
criminating ERS that misacylates mitochondrial-encoded tRNAGln
with glutamate [27]. The glutamate acylating tRNAGln is then
transamidated by the mitochondrial GatFAB amidotransferase into
glutamine yielding a correctly paired Gln-tRNAGln species. These
ﬁndings show that Arc1p, and thus the AME complex, plays the
role of an anchoring platform that regulates the subcellular loca-
tion of ERS in response to which metabolism—fermentation or res-
piration—is used by S. cerevisiae. Since the mitochondrial
transamidation reaction involving the cytosolic ERS and the Gat-
FAB AdT, is the only pathway through which yeast cells generate
the mitochondrial Gln-tRNAGln, the dynamics of AME complex is
essential for the expression of the mitochondrial genes and thus
the ability of yeast cells to respire.
To summarize, the yeast AME complex would have two differ-
ent roles. In fermenting yeast cells binding of ERS and MRS to
the AIMP protein Arc1p improves their aminoacylation efﬁciency.
Concomitantly, Arc1p (and thus the AME complex) also serves as
an anchoring platform sequestering ERS in the cytoplasm in fer-
menting cells, and releasing ERS so that it can relocate in the mito-
chondria when cells need to respire. What happens to MRS in
respiring yeast cells is still unknown. Obviously, the decrease in
Arc1p levels upon switch to respiration should also trigger the
release of MRS, and, since deletion of ARC1 triggers nuclear reloca-
tion of MRS, one could imagine that MRS could relocate to this
compartment in respiring cells to perform yet undetermined
functions.
2.1.3.2. Schizosaccharomyces pombe. Analysis of the initiation factor
3 (eIF3p) interactome in the ﬁssion yeast S. pombe [63] revealed
the presence of a translasome: a super-complex linking protein
synthesis and degradation. Seven aaRSs were identiﬁed within this
complex: threonyl-tRNA synthetase (TRS); SRS; MRS; DRS; phenyl-
alanyl-tRNA synthetase (FRS); ERS; and GRS together with a pro-
tein that was identiﬁed as a cofactor for MRS and ERS. The 7
aaRSs and the MRS and ERS cofactor protein may constitute a
MSC in S. pombe. Notably, MRS, ERS and their cofactor are the most
highly abundant proteins in this putative MSC. Thus, this study
suggests the existence in ﬁssion yeast of an MSC that would be
similar to the S. cerevisiae AME complex, composed of MRS, ERS,
and a cofactor protein that resembles Arc1p. However, it is still
not known whether the other aaRSs found in the translasome are
part of this MSC. The role of the putative S. pombe MSC is still
unknown, but it has been shown that the function of the transla-
some, of which this MSC is part of, is to increase translation
efﬁciency.
2.1.4. Protozoan MSCs
2.1.4.1. Trypanosoma brucei. A recent study revealed that the
protozoan pathogen T. brucei, which causes human African try-
panosomiasis, harbors a 1.2 MDa MSC [22].
Remarkably, this complex is organized like a mammalian MSC.
Indeed, it contains 3 AIMPs called MCP1-2-3 (for MARS Complex-
associated Proteins), which bind to at least 6 aaRSs: PRS, MRS,
DRS, glutaminyl- (QRS), alanly- (ARS) and tryptophanyl-tRNA syn-
thetase (WRS) (Fig. 1). Four of these aaRSs (PRS, MRS, DRS and QRS)
are also found in the mammalian MSC. Sequence homology
searches have revealed that the three AIMPs of T. brucei have
homologues in various organisms. For example, MCP1 has a
tRNA-binding domain and a GST-like domain and therefore resem-
bles the yeast protein Arc1p that binds ERS and MRS. Given the
sequence similarity between MCP2 and the bacterial tRNA-bindingprotein Trbp111 or eukaryotic tRNA binding proteins, it is possible
that MCP2 contains a tRNA-binding domain and does not simply
serve as a scaffold protein within the protozoan MSC. This hypoth-
esis has been conﬁrmed in in vitro studies, in which MCP2 was
shown to bind various tRNAs. Interestingly, MCP3 shares some
sequence similarity with the bacterial protein YbaK, which has
been shown to be a free-standing editing domain that deacylates
mischarged cysteinyl-tRNAPro or alanyl-tRNAPro, thereby compen-
sating the lack of these editing activities of ProRS [64,65]. Thus,
in the T. brucei MSC, MCP3 might be involved in misacylated tRNA
editing and the proofreading of aa-tRNAs generated by the MSC
aaRSs.
Overall, the role of the T. brucei MSC is probably to enhance the
catalytic efﬁciency of the aaRSs building the complex. Indeed, it
was shown that, in vitro, MCP2 increases the rate of tRNAMet
aminoacylation. Other, in vivo experiments showed that an
MCP2-deﬁcient T. brucei strain is less infectious than a wild-type
strain. Taken together, these results suggest that the MSC of T. bru-
cei is important for the parasite’s ﬁtness. Consequently, it repre-
sents an attractive drug target in the search for treatments
against human African trypanosomiasis.
2.1.4.2. Toxoplasma gondii. Recently, an MSC was isolated from the
apicomplexan, T. gondii, which is the pathogen causing toxoplas-
mosis [66]. This 1 MDa complex is localized in the cytoplasm of
the parasite and is composed of 4 aaRSs: MRS; ERS; QRS; and tyro-
syl-tRNA synthetase (YRS), and a single AIMP called Tg-p43 (T. gon-
dii p43). The 4 aaRSs are bound to Tg-p43 through their N-terminal
GST-like domains, which are similar to the GST-like domains of the
S. cerevisiae Arc1p (Fig. 1). Tg-p43 also contains a tRNA binding
domain that shares sequence similarity with both human AIMP1/
p43 and yeast Arc1p. Notably, the T. gondii MSC resembles to the
S. cerevisiae AME complex in several ways: the subcellular localiza-
tion of the complex is the same; both MSCs contain MRS and ERS;
and their AIMPs are highly similar in terms of sequence homology
and structural domains.
Interestingly, the mutant parasite in which the gene encoding
Tg-p43 has been deleted is viable and its pathogenicity is not
affected by the loss of Tg-p43. The MSC is therefore not involved
in the parasite virulence. However, it is still not known whether
binding of the 4 aaRSs to Tg-p43 modulates their catalytic efﬁcien-
cies, leaving the role of the T. gondii MSC still enigmatic.
2.1.5. Metazoan MSCs
2.1.5.1. Nematodes. The worm Caenorhabditis elegans also has a
1 MDa MSC. This MSC is composed of MRS, LRS, IRS, ERS, QRS,
RRS, KRS and valyl-tRNA synthetase (VRS) and contains an AIMP
called mrsp-38 (MARS Scaffold Protein 38 orthologue of the
AIMP2/p38) [67]. The main differences with the mammalian
MSC are that AIMP3/p18, DRS and PRS are not part of this com-
plex whereas VRS is. Another discrepancy is that MRS is fused
to a domain that resembles the mammalian AIMP1/p43 [68]. This
appended domain replaces AIMP3/p18 for anchoring of MRS to
the complex. In addition to the classical MSC components, the
chaperone protein HSP90/Daf21 and the elongation factor EF-1A
have been co-puriﬁed with the C. elegans MSC. However, the role
of these additional proteins within the MSC is not known. Hsp90/
Daf21 might be involved in the MSC assembly, whereas EF-1A
might contribute to aa-tRNA channeling to the ribosome. Some
experiments show that inactivation of MRS leads to sterility phe-
notype, but the exact role of the C. elegans MSC remains
unknown.
2.1.5.2. The mammalian MSC. The mammalian MSC is composed of
eight aaRSs: MRS; DRS; KRS; RRS; LRS; QRS; isoleucyl- (IRS); and
glutamyl-prolyl-tRNA synthetase (EPRS), and 3 AIMPs: AIMP1/
D. Laporte et al. / FEBS Letters 588 (2014) 4268–4278 4273p43; AIMP2/p38; and AIMP3/p18 (Fig. 1) [69]. The work undergone
during the last decade on the mammalian MSC revealed that these
complexes are reservoirs for releasable aaRSs used as regulatory
and signaling factors [28,29]. Indeed, the human MRS can be
released from the MSC, and relocates to the nucleolus to activate
gene transcription [31]. In humanmacrophages, bi-functional EPRS
has been shown to be released from the MSC following treatment
with c-interferon [70], thereby promoting translational silencing
of a speciﬁc set of mRNAs that encode pro-inﬂammatory proteins
[26]. Most of the MSC-participating aaRSs have been shown to be
released in response to a speciﬁc stimulus and often to relocate
to new subcellular compartments, where they exert a non-conven-
tional role that is unrelated to protein synthesis [29]. The increasedFig. 2. Distribution of GST-like and WHEP protein-binding domains in the MSC compone
their initials; top lane) that are displayed (one column for each organism) were selecte
phylogenetic interest. The presence of a GST-like (A) or WHEP domain (B) in one of the lis
is symbolized by a red or gray box respectively. AaRSs listed in (A) or (B) correspond to t
presented species (top lane). AIMPs were divided into three categories: p18-GST and p38-
Spo, Sce, Cal, Cel, Tgo and Tbr MSCs. AaRSs labeled with an asterisk (*) corresponds to tho
by PSI-Blast search using the protein sequence of the S. cerevisiae Arc1p GST-like domain
(Accession: AAI36466.1, GI:223460490) or using the protein sequence of the human MR
WHEP domain (Accession: AAI36466.1, GI:223460490) with the NCBI protein database. O
Methanothermobacter thermautotrophicus (str Delta H); Mja; Methanocaldococcus janna
discoideum (AX4), Spo; Schizosaccharomyces pombe (972 h-), Sce; Saccharomyces cerevisiae
Tbr; Trypanosoma brucei (strain 927/4 GUTat10.1), Tgo; Toxoplasma gondii (strain ME49)
Fig. 3. EMAPII-like RNA-binding domains and their distribution among aaRSs and aaRS-r
are the dimer-forming trbp111 type and the monomeric EMAPII type. The dimer-form
monomer is shown in dark green. These colors are retained for the corresponding areas
extension which folds into a structural mimic of the trbp111 dimer core, forming what ha
EMAPII are both RNA-binding. Panel B: distribution of EMAPII-like domains in 11 unicell
lane) that are displayed (one column for each organism) were selected because they hav
Shown (last column) are ﬁve sorts of protein in which these domains were found (lines):
domain, Arc1p-like GST-fused EMAPII proteins, and p43-like proteins. Dark blue bands
where EMAPII type domains were found. Shown in dark gray for comparison is the RNA
using the protein sequence of Aquifex aeolicus trbp111 (Accession: 1PYB_D; GI:34810889
the NCBI database. Organisms studied were, in full name: Tko; Thermococcus kodaka
Methanocaldococcus jannaschi (DSM 2661), Hma; Haloarcula marismortui (ATCC 43049),
Saccharomyces cerevisiae (S288C), Cal; Candida albicans (WO-1), Cel; Caenorhabditis ele
Toxoplasma gondii (strain ME49), Cre; Chlamydomonas reinhardtii (strain CC-1373).number of aaRSs and AIMPs building these MSCs in higher eukary-
otes may be viewed as a mean to expand the diversity of the
response repertoire to stimuli.
2.2. Anchoring domains found in MSC components
In metazoa, AIMPs are the pivotal components that enable
aaRSs to assemble into MSCs [71]. These assembly factors provide
the protein-binding domains required for aaRS recruitment to
MSCs and sometimes also contain RNA-binding domains that
may be involved in MSC functions. As the composition and archi-
tecture of the metazoan MSCs is relatively well conserved, the
presence of an MSC in any higher eukaryotic species can easilynts from 11 unicellular and 2 multicellular species. The organisms (abbreviated by
d because they have been shown to contain a MSC (all but Ddi and Cre), or out of
ted aaRS or AIMP protein (last columns in (A) and (B)) of the corresponding organism
hose in which a GST-like or WHEP domain has been identiﬁed in at least one of the
GST which are only present in the Hsa MSC, and Arc1p/Arc1p-like protein present in
se which have not been found in the MSC. Protein-binding domains were identiﬁed
(Accession: CAA64750.1 GI: 1620460) or that of the human EPRS GST-like domain
S WHEP domain (Accession: BAA95668.1, GI: 7804468) or that of the human EPRS
rganisms studied were, in full name: Tko; Thermococcus kodakarensis (KOD1), Mth;
schi (DSM 2661), Hma; Haloarcula marismortui (ATCC 43049) Ddi; Dictyostelium
(S288C), Cal; Candida albicans (WO-1), Cel; Caenorhabditis elegans, Hsa; Homo sapiens,
, Cre; Chlamydomonas reinhardtii (strain CC-1373).
elated proteins. Panel A: two types of EMAPII-like domains have been found. These
ing C-terminal part of trbp111 is shown in light green while the remainder of the
of EMAPII. The EMAPII type domain is homologous to trbp111 but has a C-terminal
s been called a pseudo-dyad. The dimer interface of trbp111 and the pseudodyad of
ular and 2 multicellular organisms. The organisms (abbreviated by their initials; top
e been shown to contain a MSC (all but Ddi and Cre), or out of phylogenetic interest.
small proteins estimated at 25 kDa or less mostly composed of a trbp111 or EMAPII
indicate where trbp111 type domains were found, while light blue bands indicate
-binding WHEP insertion domain of Hsa MRS. Domains were identiﬁed by PSI-Blast
) or of the H. sapiens p43 EMAPII domain (Accession: AAC60647.1, GI:833999) with
rensis (KOD1), Mth; Methanothermobacter thermautotrophicus (str Delta H), Mja;
Ddi; Dictyostelium discoideum (AX4), Spo; Schizosaccharomyces pombe (972 h-), Sce;
gans, Hsa; Homo sapiens, Tbr; Trypanosoma brucei (strain 927/4 GUTat10.1), Tgo;
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the contrary, the composition of MSCs that have been character-
ized in unicellular organisms is so diversiﬁed that the presence
of an MSC in a given species cannot be easily established. The main
reason for this is that unicellular MSCs do not systematically use
AIMPs (or easily identiﬁed appended domains) to bind and aggre-
gate aaRSs (Fig. 1). How these MSCs assemble and what protein-
binding domains are used to build these particles has still not been
extensively analysed. In this section, we list the domains known to
mediate protein- or RNA-binding that have been identiﬁed in com-
ponents of MSCs from unicellular organisms (Figs. 2 and 3).
2.2.1. Protein-binding domains
In order to form MSCs, aaRSs from eukaryotes interact with
each other and/or with AIMPs through speciﬁc protein-binding
domains such as GST-like domains or WHEP domains. Leucine zip-
per (LZ) are also involved for the formation of complexes in higher
eukaryotes but have not yet been found in aaRSs from lower
eukaryotes and are therefore not described in this section. UNE-X
domains, unique domains speciﬁc to each aaRS, are not described
in this section because they are not always protein- or RNA-bind-
ing domains [72].
2.2.1.1. GST-like domains. In lower eukaryotes, GST-like domains
have been shown to mediate the formation of homo and heterodi-
mers. For example, in the AME complex of the budding yeast S.
cerevisiae, MRS and ERS associate with the anchoring protein AIMP
Arc1p via GST-like domains of the N-terminal regions of all three
proteins [19]. Among lower eukaryotes, GST-like domains have
also been found in ERS and MRS from S. pombe, Candida albicans
and T. gondii, in ERS of Dictyostelium discoideum, but also in
Arc1p-like proteins from S. pombe, C. albicans and D. discoideum
as well as in Tg p43 of T. gondii (Fig. 2). Interestingly, the GST-like
domain of a D. discoideum Arc1p-like protein has a higher similar-
ity with GST-like domains frommetazoa (33% of identities and 61%
of similarities with the GST-like domain of EPRS from Homo sapi-
ens) than GST-like domains from yeast, in accordance with the pro-
teome of D. discoideum [73]. The presence of GST-like domains in
several aaRSs and anchoring Arc1p-like proteins in C. albicans
and D. discoideum suggests that aaRSs might assemble into MSCs
in these organisms. The identiﬁcation of such MSCs will give us
insights into not only protein-binding domains, but also the strat-
egy used for MSC assembly (i.e.with an anchoring factor or with an
aaRSs).
In metazoans, the number of aaRSs participating to MSCs is
higher than in lower organisms (between 9 and 12 in H. sapiens
depending on the counting and 8 in C. elegans), and concomitantly,
the number of aaRSs harboring GST-like domains is also higher (4
for H. sapiens and for C. elegans). GST-like domains could then be
seen as a means to strengthen interactions in MSCs, eventually
leading to more diverse role like interactions with other partners
to accomplish additional functions such as the interaction between
the GST-like domain of human CRS with eEF-1H [74].
2.2.1.2. WHEP domains. The WHEP protein–binding domain has
been reported to be strictly restricted to aaRSs of higher eukary-
otes. This domain has been named after its presence in WRS, histi-
dyl-tRNA synthetase (HRS) and EPRS and consists of 46 amino
acids organized into a Helix-Turn-Helix (HTH) fold. WHEP domains
are involved in protein–protein interactions, but also in RNA bind-
ing. They are mostly located in the aaRS N-terminus (as, for exam-
ple, in HRS, GRS and WRS from H. sapiens) and less commonly in
the aaRS C-terminus (MRS in H. sapiens and ERS in C. elegans).
Exceptionally they can also occupy a central position like in human
EPRS, in which 3 WHEP repeats link the ERS and the PRS fused
sequences. In this fusion enzyme, WHEP repeats were ﬁrst shownto be able to bind RNA [75–77], but a recent study revealed that
WHEP repeats bind proteins as well: for example, non-structural
associated protein (NSAP1), associates with the third WHEP repeat
of EPRS [78]. However, compared to the GST domain which is the
major domain mediating MSC assembly, the use of the WHEP
domain to anchor aaRSs in MSCs is limited to a few MSC-partici-
pating aaRSs. In addition, half of the WHEP-containing aaRSs do
not participate to MSCs (GRS, WRS and HRS), suggesting that the
presence of WHEP domains in aaRSs from a given species is not a
strong indicator that they will assemble into a MSC.
In lower eukaryotes aaRSs, only one WHEP domain could be
identiﬁed, namely in the S. pombe HRS (Fig. 2), and interestingly
this aaRS is not part of the translasome [79]. However, it remains
unclear whether this domain in S. pombe is involved in RNA-bind-
ing or protein–protein interactions. HRS from various organisms
share low similarities in their N-terminal parts, and a study per-
formed on T. brucei revealed that the N-terminal part of HRS forms
a HTH domain [80], whereas in H. sapiens, this region harbors a
WHEP domain. The ﬁnding that WHEP domains were acquired
early in the history before the separation of plants and animals
[81] re-opens the debate of how and why some aaRSs have gained
and retained this domain.
2.2.1.3. Other unclassiﬁed protein-binding domains. In archaeal
aaRSs, no authentic protein-binding domains like the GST-like
domains or WHEP domains could be found (Fig. 2). However, it
has been shown that M. thermautotrophicus LRS interacts with
KRS and PRS [82]. As mentioned previously (Section 2.1.1), KRS
and PRS interact with the N- and C-terminal part of LRS, respec-
tively. The C-terminal extension of PRS could mediate this interac-
tion [83]. In contrast, in H. sapiens and C. elegans, the C-terminal
part of LRS binds to the leucine-zipper (LZ) of RRS in their respec-
tive MSCs [84]. Further work is needed to characterize the domains
or folds by which archaeal aaRSs participating in MSCs bind to each
other.
2.2.2. tRNA-binding domains
EMAPII-like domains attracted the attention of researchers
working in the ﬁeld when it was discovered that this domain had
a cytokine activity. The name EMAPII comes from: Endothelial
Monocyte-Activating Polypeptide II, and corresponds to the cyto-
kine activity that was ﬁrst described for this domain [85]. It was
later found that the precursor of EMAPII is the AIMP1/p43 of the
MSC present in higher eukaryotes [21]. EMAPII-like domains were
then also identiﬁed as individual and autonomous proteins, like
Trbp111 in Aquifex aeolicus, and CsaA in Bacillus subtilis. Impor-
tantly, EMAPII is often found at the C-terminus of MRS in various
organisms [86–88].
Structural studies showed that EMAPII-like domains can be
divided into two categories: the shorter type resembling trbp111
(trbp111-like), which serves as a dimerization domain; and the
longer EMAPII type, which has a C-terminal extension that pre-
vents dimerization. This longer EMAPII type bears structural simi-
larity to the interface of the dimerized trbp111 (Fig. 3A), which is
also called ‘‘pseudo-dyad’’ and forms an RNA-binding site. Conse-
quently, the presence of a trbp111-like domain in some bacterial
and archaeal MRSs enables their dimerization. In higher eukary-
otes, MRSs most probably cannot dimerize, as the trbp111-like
domain is replaced by the pseudo-dyad type of EMAPII [89].
The appearance in eukaryotes of the pseudo-dyad type of EMA-
PII that is unable to dimerize coincides with the appearance of
EMAPII-like domains in aaRSs other than MRS, as well as in AIMPs.
In many of the organisms in which MSCs have been found, EMAPII-
like domains seem to be present either in MRS or in AIMPs, includ-
ing Arc1p and AIMP1/p43, but very rarely in both (Fig. 3B). This
could be due to the transfer of the tRNA-binding role, within a
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AME complex, EMAPII is located in the C-terminus of Arc1p and
absent from MRS. If this EMAPII domain would be fused to the C-
terminus to MRS instead this domain would likely also be able to
bind tRNA in a similar manner as it does in the Arc1p scaffold
[90]. However, the reason why EMAPII is located in Arc1p rather
than in MRS is that Arc1p requires a tRNA binding domain to
export tRNAs from the nucleus [91]. EMAPII domains are not only
RNA-binding domains but also signaling entities, and EMAPII
domains released from human AIMP1/p43 and YRS following
cleavage have distinct functions [21,92]. This signaling role is not
restricted to EMAPII domains of higher eukaryotes, as the unicellu-
lar parasite Entamoeba histolytica, overexpresses MRS and KRS in
response to inﬂammatory signals, and the C-terminal EMAPII
domains of these enzymes are released following cleavage to mod-
ulate host immune response [93]. Although no MSC has yet been
identiﬁed in Entamoeba, similar signaling functions may eventuallyFig. 4. Existence of two types of MSCs in low complexity organisms. Based on their assem
classes of aaRSs, MSCs from unicellular organisms segregate into either an archaeal- (
highlight each of the 3 features (listed in the middle of the ﬁgure) that were used for the
non-conventional components and the aaRSs corresponding to most represented cla
components shaded.be found for EMAPII-containing AIMPs or MSC-participating aaRSs
of other lower eukaryotes.
2.3. The diversity of assembly modes in MSCs from low complexity
organisms
Whereas in higher eukaryotes there seems to be a conserved
architecture and strategy to assemble MSCs, in unicellular organ-
isms, the composition and assembly modes of MSCs is far more
diverse (Fig. 1) and unpredictable. The diversity of the proteins
(AIMPs, aaRSs or unrelated proteins) and protein-binding domains
mediating assembly of these complexes makes the validation of
the presence of a MSC in a given species using bioinformatics unre-
liable. For example, MSCs in eukaryotes, especially the metazoa,
assemble with the help of interaction domains that are found
either on aaRSs or on AIMPs. The extent to which this occurs is
slightly lesser in the case of unicellular eukaryotes such asbly mode, the presence of non-conventional components and the most represented
top, green) or eukaryal-type (bottom, orange) complex. Shades (green or orange)
classiﬁcation of the presented MSCs. Proteins mediating assembly of the MSCs, the
ss of aaRSs participating to these MSCs are shown in bold, with the remaining
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domains like EMAPII, GST-like and WHEP (either in aaRSs or AIM-
Ps) are less commonly found. In archaea, the trend toward simplic-
ity continues and aaRSs assemble into MSCs apparently without
the help of any well-deﬁned protein-binding domains. As such,
the difﬁculty in predicting from genomic data whether or not an
MSC may exist in a given organism may prove to be inversely pro-
portional to its complexity. In the eukaryotes, the presence of
WHEP domains on aaRSs, or the presence of genes encoding the
EMAPII domain in conjunction with GST-like or EF-Tu-like domains
are good indicators of the presence of an MSC. More robust exper-
iments could then conﬁrm this, as well as discover any novel or
unusual components of an MSC (such as MCP3 from T. brucei). In
prokaryotes, the scarcity of well-deﬁned MSC-forming domains
means that predicting the presence of MSCs may remain difﬁcult,
and highly dependent on classical experimental methods.
Despite this diversity, we attempted to classify MSCs from low
complexity organisms by looking at three characteristic traits of
MSCs: their mode of assembly and assembly factor, the presence
or absence of non-conventional components; and the types of
aaRSs that participate in these complexes. This analysis led us to
propose that two different assembly modes and types of unicellu-
lar MSCs have emerged during evolution: the archaeal and eukar-
yal MSCs (Fig. 4).
The ﬁrst distinctive feature between archaeal and lower eukary-
ote MSCs is their mode of assembly. In unicellular eukaryotes MSCs
always assemble through protein–protein interaction domains that
are present on AIMPs. Importantly, AIMPs from lower eukaryotes
are structural homologs of the metazoan AIMPs. By contrast, in
all archaeal MSCs that have been described so far, complex forma-
tion is mediated by aaRSs, or other assembly factors, such as elon-
gation factors or ribosomal proteins, but not by AIMPs. It is still
largely unknown what domains of these aaRSs, elongation factors
or ribosomal proteins mediate the protein–protein interactions
involved in MSC assembly. However, most of the archaeal species
in which MSCs have been characterized are thermophiles; and in
these organisms proteins have a tendency to assemble in com-
plexes through the use of hydrophobic patches. This propensity
to aggregate is often considered as an adaptation of these organ-
isms to the extreme temperatures of their environment [94]. One
possibility is that these hydrophobic patches could also be used
to assemble archaeal MSCs.
The second idiosyncratic feature of the archaeal MSC is the
presence of non-conventional components. Ribosomal proteins,
translation factors (often elongation factors), or even metabolic
enzymes are found in archaeal MSCs. These types of proteins are
never found in eukaryal MSCs despite the fact that they are often
indirectly linked to eukaryal MSCs. Indeed, a wide range of organ-
isms has been shown to contain translasomes that gather several
components of the translation machinery, including MSCs, in a
huge mega-complex [67,95,96]. This association of components
of the translational machinery with the MSC makes sense because
it allows tRNA channeling, recycling and, by avoiding diffusion of
aa-tRNA in the cell, improves the rate of mRNA codon reading.
The third major difference between archaeal and eukaryotic
MSCs is a bias in aaRS composition. AaRSs segregate in two
different classes, class 1 and class 2, mainly based on the fold of
their aa- and ATP recognition domain [97]. In archaeal MSCs there
are often more class 2 aaRSs than class 1 whereas in eukaryotes
class 1 aaRSs are always the most abundant (Fig. 4). Moreover,
PRS (a class 2 aaRS) is the most abundant aaRS found in archaeal
MSCs (in 3 out of the 5 MSC), whereas MRS and ERS (class 1 aaRSs)
are systematically present in the lower eukaryote MSCs.
The fact that PRS is the most abundant aaRSs in archaeal MSCs
may be simply related to the properties of archaeal PRS. Indeed
some of these enzymes, unlike their bacterial orthologues, aredeprived of editing domains and have an additional C-terminal
extension that can thus be used for complex assembly [83,98,99].
The presence of MRS in MSCs from all unicellular eukaryotes
may be related to its role as a sensor of oxidative stress. Indeed,
it has been shown, from fungi to mammals, that MRS methiony-
lates non-cognate tRNAs under oxidative stress. In S. cerevisiae,
mismethionylated tRNAs can be used by translating ribosomes
[60]. This mechanism is conserved in human cells [100]. tRNA mis-
methionylation leading to an increased content of methionine in
the proteome protects the organism against oxidative through
the scavenging of reactive oxygen species (ROS) [61]. As in unicel-
lular eukaryotes MSC-bound MRS is always more efﬁcient in charg-
ing tRNA with methionine, its recruitment in MSCs may be viewed
as one way to boost the response to oxidative stress.
MSCs may also provide a link between metabolism and protein
translation. Indeed, inM. jannaschii, aaRSs form a complex with the
paralogue of a metabolic enzyme that is inactive but sensitive to H2
concentrations [45,46], thereby linking aa-tRNA synthesis to meth-
anogenesis. Likewise, AIMPs such as the S. cerevisiae Arc1p and the
human AIMP1/p43 seem to have a recurrent link with glucose
metabolism or sensing. Indeed, Arc1p expression decreases upon
glucose depletion [27], and AIMP1/p43 is a known cytokine
involved in a wide range of functions including the regulation of
glucose metabolism [101]. Noteworthy is the fact that the S. cere-
visiae ERS (which also participates in the MSC) is linked to the glu-
cose metabolism, and its mitochondrial import in respiring cell is
essential [27].
To summarize, bacterial MSC has been identiﬁed only in E. coli
and archaea and lower eukaryotes contain distinct MSCs, with dif-
ferences in their modes of assembly, components and in the line-
age of their aaRSs. The feeling that emerges from the studies
made on these MSCs is that the major role for these archaeal and
eukaryal MSCs would be to enhance aa-tRNA synthesis and to
channel this molecule to the ribosome. However, without further
work on the characterized MSCs from low complexity organisms
and additional sampling of more species, the reason why these uni-
cellular organisms contain MSCs will still remain mostly obscure.
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